CD34 and acute myeloid leukemia: Apigenin was used for CK2 inhibition and LY294002 for PI3K–Akt inhibition in this study, and a proapoptotic effect was seen for the CD34+CD38− AML cell population, which is regarded as being enriched of leukemic stem cells.